$2.97 -0.51 (-15.32%)
Q32 Bio Inc. Common Stock (QTTB)
Q32 Bio Inc. is a biotechnology company focused on developing novel therapies for rare and underserved diseases. The company leverages its expertise in drug discovery and development to create innovative treatments aimed at improving patient outcomes.
Company News
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are...